Mon, 23rd Feb 2015 17:11
OTTAWA, Feb 23 (Reuters) - Canada's Competition Bureau onMonday approved a deal between GlaxoSmithKline PLC andNovartis AG, noting in a statement that U.S.authorities had already said the transaction could go ahead.
The companies agreed last April to the transaction thatincludes GSK buying Novartis' vaccines business, Novartispurchasing GSK's cancer drugs, and the two groups tying up inconsumer healthcare. (Reporting by David Ljunggren)
(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:
CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U....
FTSE 100 down 0.3%, FTSE 250 off 0.2% *
(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal...
(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending polic...
Glaxosmithkline (GSK)